Cresset Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Cresset Asset Management's HALO Position: Q2 2026 in Review
Cresset Asset Management increased its Halozyme (HALO) stake by 0.59% in Q2 2026, buying an estimated $105K and bringing the position to 260,937 shares worth $20.4M. The position accounts for 0.07% of the portfolio, ranked #158.
Cresset Asset Management first reported a position in HALO in Q2 2023 and has held it in 13 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Cresset Asset Management held 260,937 shares of Halozyme worth $20.4M as of Q2 2026.
- Cresset Asset Management bought 1,540 Halozyme shares in Q2 2026, an estimated $105K.
- Halozyme made up 0.07% of Cresset Asset Management's portfolio in Q2 2026, its #158 holding.
- Cresset Asset Management first reported a position in Halozyme in Q2 2023 and has held it in 13 quarters since.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.